Withdrawal statement
The authors have withdrawn their manuscript due to becoming aware of methodology issues related to the curation of the training set used to determine cut-off values for Biotyper cluster assignation and lack of replicate measurements on different days for the isolates analysed. It is therefore unclear whether the conclusions of the manuscript are founded and no further work is possible to correct these issues as the instrument is no longer available to the authors. If you have any questions, please contact the corresponding author.
Competing Interest Statement
The authors acknowledge Bruker for loaning an IR Biotyper instrument for the purposes of this analysis and for technical support during the course of the study; Bruker had no role in the design of the study or the interpretation of the results.
Funding Statement
This work was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare-Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with UK Health Security Agency (UKHSA) [grant NIHR200915]. The computational aspects of this research were funded from the NIHR Oxford BRC with additional support from a Wellcome Trust Core Award Grant [grant 203141/Z/16/Z]. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or the UK Health Security Agency. NS is an NIHR Oxford BRC Senior Research Fellow and an Oxford Martin Fellow.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
